| Authors: |
Hellier V; GIGA Neurosciences, Neuroendocrinology, University of Liege, 4000, Liege, Belgium., Brock O; GIGA Neurosciences, Neuroendocrinology, University of Liege, 4000, Liege, Belgium.; Netherlands Institute for Neuroscience, 1105 BA, Amsterdam, The Netherlands., Candlish M; Experimental Pharmacology, Center for Molecular Signaling (PZMS), Saarland University School of Medicine, 66421, Homburg, Germany., Desroziers E; GIGA Neurosciences, Neuroendocrinology, University of Liege, 4000, Liege, Belgium., Aoki M; Experimental Pharmacology, Center for Molecular Signaling (PZMS), Saarland University School of Medicine, 66421, Homburg, Germany., Mayer C; NYU School of Medicine, New York, NY, 10016, USA., Piet R; Center for Neuroendocrinology and Department of Physiology, University of Otago, Dunedin, 9054, New Zealand., Herbison A; Center for Neuroendocrinology and Department of Physiology, University of Otago, Dunedin, 9054, New Zealand., Colledge WH; Reproductive Physiology Group, Department of Physiology, Development, and Neuroscience, University of Cambridge, Cambridge, CB2 3EG, UK., Prévot V; Laboratory of Development and Plasticity of the Neuroendocrine Brain, Jean-Pierre Aubert Research Center, Inserm U1172, F- 59000, Lille Cedex, France., Boehm U; Experimental Pharmacology, Center for Molecular Signaling (PZMS), Saarland University School of Medicine, 66421, Homburg, Germany. ulrich.boehm@uks.eu., Bakker J; GIGA Neurosciences, Neuroendocrinology, University of Liege, 4000, Liege, Belgium. jbakker@uliege.be.; Netherlands Institute for Neuroscience, 1105 BA, Amsterdam, The Netherlands. jbakker@uliege.be. |
